Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fugan Ointment (ZL-3101) in Subacute Eczema
NCT03134352Phase 2Completed
- Sponsor
- Zai Lab
- Start
- Apr 2017
- Primary completion
- May 2018
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZL-3101 in Eczema, sponsored by Zai Lab. Started Apr 2017; status: completed.
02
Drugs
ZL-3101
03
Conditions
Eczema
Beyond the preview
Go deeper on NCT03134352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03134352.